Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-034395
Date:2022-06-02
Issuer: RXSIGHT, INC. (RXST)
Original Submission Date:

Reporting Person:

PALMISANO ROBERT J
C/O RXSIGHT, INC.
100 COLUMBIA ALISO VIEJO, CA 92656

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-06-02 A 8,624 a $0.00 22,002 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 each restricted stock unit ("rsu") represents a contingent right to receive one share of rxsight, inc. common stock.
f2 subject to the reporting person's continuing as an outside director (as defined in the issuer's 2021 equity incentive plan) through such applicable vesting date, one hundred percent (100%) of the rsus subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the date of grant or (ii) the date immediately prior to the next annual meeting of stockholders following the date of grant. "date of grant" shall mean june 2, 2022.

Elevate your investments